# Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

> **NCT06052527** · — · COMPLETED · sponsor: **Lizora LLC** · enrollment: 27 (actual)

## Conditions studied

- COVID-19
- Post-COVID-19 Syndrome
- Influenza

## Interventions

- **OTHER:** Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning

## Key facts

- **NCT ID:** NCT06052527
- **Lead sponsor:** Lizora LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-16
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-10-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06052527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06052527, "Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06052527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*